Play Video
1
Aplastic Anemia
Aplastic Anemia
::2012/05/29::
Play Video
2
Johns Hopkins Medicine: Aplastic Anemia
Johns Hopkins Medicine: Aplastic Anemia
::2009/09/21::
Play Video
3
Aplastic Anemia
Aplastic Anemia
::2009/01/06::
Play Video
4
Mia and Aplastic Anemia
Mia and Aplastic Anemia
::2011/03/26::
Play Video
5
Aplastic Anaemia : Definition, Aetiology, Clinical Features, Diagnosis, Treatment, Prognosis (HD)
Aplastic Anaemia : Definition, Aetiology, Clinical Features, Diagnosis, Treatment, Prognosis (HD)
::2013/12/25::
Play Video
6
What
What's New in Aplastic Anemia Treatment?
::2012/01/22::
Play Video
7
Coping with Aplastic Anemia - Emily
Coping with Aplastic Anemia - Emily's Story
::2012/09/21::
Play Video
8
My Aplastic Anemia story
My Aplastic Anemia story
::2012/01/16::
Play Video
9
Dr. Neal Young, NIH, discusses aplastic anemia at the 2013 ASH Annual Meeting
Dr. Neal Young, NIH, discusses aplastic anemia at the 2013 ASH Annual Meeting
::2013/12/18::
Play Video
10
Aplastic Anemia Cause, Symptoms and Treatments
Aplastic Anemia Cause, Symptoms and Treatments
::2008/12/18::
Play Video
11
My life with aplastic anemia & MDS
My life with aplastic anemia & MDS
::2014/03/11::
Play Video
12
David
David's Story and Severe Aplastic Anemia Signs and Symptoms
::2013/12/01::
Play Video
13
Aplastic Anemia: Never Let Go - Bai Xue
Aplastic Anemia: Never Let Go - Bai Xue
::2013/07/11::
Play Video
14
24 Oras: Dalagitang may aplastic anemia, kailangan ng dalawang bag ng dugo araw-araw
24 Oras: Dalagitang may aplastic anemia, kailangan ng dalawang bag ng dugo araw-araw
::2014/07/14::
Play Video
15
Aplastic Anemia & Chronic Kidney Disease Related Anemia
Aplastic Anemia & Chronic Kidney Disease Related Anemia
::2013/10/23::
Play Video
16
Tell Me a Story: Sister
Tell Me a Story: Sister's Bone Marrow Gives Boy with Aplastic Anemia Life
::2010/11/04::
Play Video
17
David
David's Story, Severe Aplastic Anemia, and a Bone Marrow Transplant
::2013/11/29::
Play Video
18
Severe Aplastic Anemia
Severe Aplastic Anemia
::2010/05/12::
Play Video
19
Aplastic Anemia Journey: Bone Marrow Transplant part 1, 22 days till admission
Aplastic Anemia Journey: Bone Marrow Transplant part 1, 22 days till admission
::2011/12/20::
Play Video
20
Matt Fioretti: Aplastic Anemia Survivor
Matt Fioretti: Aplastic Anemia Survivor
::2009/07/02::
Play Video
21
My Fight with with severe aplastic anemia
My Fight with with severe aplastic anemia
::2008/07/09::
Play Video
22
My Aplastic Anemia Story - Cancer Center Sarasota Bradenton
My Aplastic Anemia Story - Cancer Center Sarasota Bradenton
::2010/12/15::
Play Video
23
Aplastic Anemia & MDS Int
Aplastic Anemia & MDS Int'l Fdn - Garrett Hamm's Story
::2010/01/07::
Play Video
24
4Victoria_Severe Aplastic Anemia
4Victoria_Severe Aplastic Anemia
::2012/07/18::
Play Video
25
Ovary tissue freezing for aplastic anemia patient
Ovary tissue freezing for aplastic anemia patient
::2011/05/11::
Play Video
26
First Line and Alternative Treatments for Aplastic Anemia - an interview with Dr. Judith Marsh
First Line and Alternative Treatments for Aplastic Anemia - an interview with Dr. Judith Marsh
::2014/04/08::
Play Video
27
107. Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes
107. Aplastic Anemia, Myelodysplasia, and Related Bone Marrow Failure Syndromes
::2013/05/09::
Play Video
28
William Prather of Pluristem on treating Aplastic Anemia with stem cells - at Stem Cells USA 2012
William Prather of Pluristem on treating Aplastic Anemia with stem cells - at Stem Cells USA 2012
::2012/12/20::
Play Video
29
Aplastic Anemia Treatment Using Cord Blood Stem Cells
Aplastic Anemia Treatment Using Cord Blood Stem Cells
::2014/05/19::
Play Video
30
Bellas Severe Aplastic Anemia Journey
Bellas Severe Aplastic Anemia Journey
::2013/03/12::
Play Video
31
Ayurvedic Remedy for Aplastic Anemia - By Panditha Elchuri
Ayurvedic Remedy for Aplastic Anemia - By Panditha Elchuri
::2014/05/15::
Play Video
32
Aplastic Anemia What You Need to Know
Aplastic Anemia What You Need to Know
::2014/07/11::
Play Video
33
Aplastic Anemia 101
Aplastic Anemia 101
::2014/02/26::
Play Video
34
David
David's Story, Severe Aplastic Anemia, and BMT (Day -7)
::2013/12/05::
Play Video
35
Growth Factors in MDS and Aplastic Anemia
Growth Factors in MDS and Aplastic Anemia
::2014/07/11::
Play Video
36
Aplastic Anemia Current Thinking on the Disease 3
Aplastic Anemia Current Thinking on the Disease 3
::2014/02/26::
Play Video
37
Frequently Asked Questions about Aplastic Anemia
Frequently Asked Questions about Aplastic Anemia
::2014/02/27::
Play Video
38
Hurdle Talk Aplastic Anemia
Hurdle Talk Aplastic Anemia
::2013/09/23::
Play Video
39
Victoria
Victoria's battle with Aplastic Anemia 재생 불능성 빈혈을 앓고 있는 우리 딸 승리
::2012/07/03::
Play Video
40
Aplastic Anemia 101
Aplastic Anemia 101
::2014/07/11::
Play Video
41
Aplastic Anemia
Aplastic Anemia
::2009/12/03::
Play Video
42
Aplastic Anemia Update: Seiji Kojima
Aplastic Anemia Update: Seiji Kojima
::2012/10/04::
Play Video
43
Aplastic Anemia Current Thinking on the Disease ,Diagnoses, and Non- Transplant Treatment
Aplastic Anemia Current Thinking on the Disease ,Diagnoses, and Non- Transplant Treatment
::2014/07/11::
Play Video
44
Josef
Josef's Aplastic Anemia Journey...the beginning
::2008/06/16::
Play Video
45
17yr boy suffering due aplastic anemia
17yr boy suffering due aplastic anemia
::2014/04/01::
Play Video
46
Aplastic Anemia Clinical Update for Patients
Aplastic Anemia Clinical Update for Patients
::2014/07/10::
Play Video
47
Bone Marrow Transplantation for Pediatric Aplastic Anemia Patients
Bone Marrow Transplantation for Pediatric Aplastic Anemia Patients
::2014/07/11::
Play Video
48
Aplastic Anemia & MDS Int
Aplastic Anemia & MDS Int'l Fdn - Kate & Louis Hablas, story of hope
::2010/01/27::
Play Video
49
SAM Interview with Aplastic Anemia Survivor Kinsey
SAM Interview with Aplastic Anemia Survivor Kinsey
::2014/08/12::
Play Video
50
MDS Aplastic Anemia and PNH in 2012
MDS Aplastic Anemia and PNH in 2012
::2014/07/15::
NEXT >>
RESULTS [51 .. 101]
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aplastic anemia
Classification and external resources
ICD-10 D60-D61
ICD-9 284
OMIM 609135
DiseasesDB 866
MedlinePlus 000554
eMedicine med/162
MeSH D000741

Aplastic anemia (AA) is a disease in which the bone marrow, and the blood stem cells that reside there, are damaged.[1] This causes a deficiency of all three blood cell types (pancytopenia): red blood cells (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia).[2][3] Aplastic refers to inability of the stem cells to generate the mature blood cells.

It is most prevalent in people in their teens and twenties, but is also common among the elderly. It can be caused by exposure to chemicals, drugs, radiation, infection, immune disease, and heredity; in about half the cases, the cause is unknown.[2][3]

The definitive diagnosis is by bone marrow biopsy; normal bone marrow has 30-70% blood stem cells, but in aplastic anemia, these cells are mostly gone and replaced by fat.[2][3]

First line treatment for aplastic anemia consists of immunosuppressive drugs, typically either anti-lymphocyte globulin or anti-thymocyte globulin, combined with corticosteroids and cyclosporine. Hematopoietic stem cell transplantation is also used, especially for patients under 30 years of age with a related, matched marrow donor.[2][3] In February 2014, the oral thrombopoietin analog eltrombopag was approved by the FDA for the treatment of patients who are refractory to immunosuppression. This additional treatment option is the first of its class, and represents a significant advancement in the prognosis and treatment of patients with aplastic anemia.[4]

Signs and symptoms[edit]

Causes[edit]

Aplastic anemia can be caused by exposure to chemicals, drugs, radiation, infection, immune disease, and heredity; in about half the cases, the cause is unknown.[2][3]

Aplastic anemia is also sometimes associated with exposure to toxins such as benzene, or with the use of certain drugs, including chloramphenicol, carbamazepine, felbamate, phenytoin, quinine, and phenylbutazone. Many drugs are associated with aplasia mainly according to case reports, but at a very low probability. As an example, chloramphenicol treatment is followed by aplasia in less than one in 40,000 treatment courses, and carbamazepine aplasia is even rarer.[citation needed]

Exposure to ionizing radiation from radioactive materials or radiation-producing devices is also associated with the development of aplastic anemia. Marie Curie, famous for her pioneering work in the field of radioactivity, died of aplastic anemia after working unprotected with radioactive materials for a long period of time; the damaging effects of ionizing radiation were not then known.[citation needed]

Aplastic anemia is present in up to 2% of patients with acute viral hepatitis.[5]

One known cause is an autoimmune disorder in which white blood cells attack the bone marrow.[citation needed]

Short-lived aplastic anemia can also be a result of parvovirus infection. In humans, the P antigen (also known as globoside) is the cellular receptor for parvovirus B19 virus that causes erythema infectiosum (fifth disease) in children. Parvovirus causes complete cessation of red blood cell production. In most cases, this goes unnoticed, as red blood cells live on average 120 days, and the drop in production does not significantly affect the total number of circulating red blood cells. In people with conditions where the cells die early (such as sickle cell disease), however, parvovirus infection can lead to severe anemia.[citation needed]

In some animals, aplastic anemia may have other causes. For example, in the ferret (Mustela putorius furo), it is caused by estrogen toxicity, because female ferrets are induced ovulators, so mating is required to bring the female out of heat. Intact females, if not mated, will remain in heat, and after some time the high levels of estrogen will cause the bone marrow to stop producing red blood cells.[citation needed]

Diagnosis[edit]

The condition needs to be differentiated from pure red cell aplasia. In aplastic anemia, the patient has pancytopenia (i.e., anemia, neutropenia and thrombocytopenia) resulting in decrease of all formed elements. In contrast, pure red cell aplasia is characterized by reduction in red cells only. The diagnosis can only be confirmed on bone marrow examination. Before this procedure is undertaken, a patient will generally have had other blood tests to find diagnostic clues, including a complete blood count, renal function and electrolytes, liver enzymes, thyroid function tests, vitamin B12 and folic acid levels.

The following tests aid in determining differential diagnosis for aplastic anemia:

  1. Bone marrow aspirate and biopsy: to rule out other causes of pancytopenia (i.e. neoplastic infiltration or significant myelofibrosis).
  2. History of iatrogenic exposure to cytotoxic chemotherapy: can cause transient bone marrow suppression
  3. X-rays, computed tomography (CT) scans, or ultrasound imaging tests: enlarged lymph nodes (sign of lymphoma), kidneys and bones in arms and hands (abnormal in Fanconi anemia)
  4. Chest X-ray: infections
  5. Liver tests: liver diseases
  6. Viral studies: viral infections
  7. Vitamin B12 and folate levels: vitamin deficiency
  8. Blood tests for paroxysmal nocturnal hemoglobinuria
  9. Test for antibodies: immune competency

Treatment[edit]

Treating immune-mediated aplastic anemia involves suppression of the immune system, an effect achieved by daily medicine intake, or, in more severe cases, a bone marrow transplant, a potential cure.[6] The transplanted bone marrow replaces the failing bone marrow cells with new ones from a matching donor. The multipotent stem cells in the bone marrow reconstitute all three blood cell lines, giving the patient a new immune system, red blood cells, and platelets. However, besides the risk of graft failure, there is also a risk that the newly created white blood cells may attack the rest of the body ("graft-versus-host disease"). In young patients with an HLA matched sibling donor, bone marrow transplant can be considered as first-line treatment, patients lacking a matched sibling donor typically pursue immunosuppression as a first-line treatment, and matched unrelated donor transplants are considered a second-line therapy.

Medical therapy of aplastic anemia often includes a course of antithymocyte globulin (ATG) and several months of treatment with a cyclosporin to modulate the immune system. Chemotherapy with agents such as cyclophosphamide may also be effective but has more toxicity than ATG. Antibody therapy, such as ATG, targets T-cells, which are believed to attack the bone marrow. Corticosteroids are generally ineffective,[citation needed] though they are used to ameliorate serum sickness caused by ATG. Normally, success is judged by bone marrow biopsy 6 months after initial treatment with ATG.[7] New treatment options include eltrombopag, which has shown promise as treatment for both moderate (non-severe) aplastic anemia, as well as severe aplastic anemia that is refractory to traditional immunosuppression.[4]

One prospective study involving cyclophosphamide was terminated early due to a high incidence of mortality, due to severe infections as a result of prolonged neutropenia.[7]

In the past, before the above treatments became available, patients with low leukocyte counts were often confined to a sterile room or bubble (to reduce risk of infections), as in the case of Ted DeVita.[8]

Follow-up[edit]

Regular full blood counts are required to determine whether the patient is still in a state of remission.

Many patients with aplastic anemia also have clones of cells characteristic of the rare disease paroxysmal nocturnal hemoglobinuria (PNH, anemia with thrombopenia and/or thrombosis), sometimes referred to as AA/PNH. Occasionally PNH dominates over time, with the major manifestation intravascular hemolysis. The overlap of AA and PNH has been speculated to be an escape mechanism by the bone marrow against destruction by the immune system. Flow cytometry testing is performed regularly in people with previous aplastic anemia to monitor for the development of PNH.

Prognosis[edit]

Untreated, severe aplastic anemia has a high risk of death. Treatment, by drugs or stem cell transplant, has a 5-year survival of about 70%, with younger age associated with higher survival.

Survival rates for stem cell transplant vary depending on age and availability of a well-matched donor. Five year survival rates for patients who receive transplants has been shown to be 82% for patients underneath the age of 20, 72% for those 20–40 years of age and closer to 50% for patients over the age of 40. Success rates are better for patients who have donors that are matched siblings and worse for patients who receive their marrow from unrelated donors.[9]

Older people (who are generally too frail to undergo bone marrow transplants) and people who are unable to find a good bone marrow match, who undergo immune suppression have five year survival rates of up to 75%.[citation needed]

Relapses are common. Relapse following ATG/cyclosporin use can sometimes be treated with a repeated course of therapy. In addition, 10-15% of severe aplastic anemia cases evolve into MDS and leukemia.[citation needed]

Milder disease can resolve on its own.[citation needed]

See also[edit]

References[edit]

  1. ^ Acton, Ashton (22 July 2013). Aplastic Anemia (in English). ScholarlyEditions. p. 36. ISBN 9781481650687. "Aplastic anemia (AA) is a rare bone marrow failure disorder with high mortality rate, which is characterized by pancytopenia and and an associated increase in the risk of hemorrhage, infection, organ dysfunction and death." 
  2. ^ a b c d e Kasper, Dennis L; Braunwald, Eugene; Fauci, Anthony; et al. (2005). Harrison's Principles of Internal Medicine, 16th ed. New York: McGraw-Hill. ISBN 978-0-07-140235-4. 
  3. ^ a b c d e Merck Manual, Professional Edition, Aplastic Anemia (Hypoplastic Anemia)
  4. ^ a b Desmond, R; Townsley, DM; Dumitriu, B; Olnes, MJ; Scheinberg, P; Bevans, M; Parikh, AR; Broder, K; Calvo, KR; Wu, CO; Young, NS; Dunbar, CE (Mar 20, 2014). "Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.". Blood 123 (12): 1818–25. doi:10.1182/blood-2013-10-534743. PMID 24345753. Retrieved 28 March 2014. 
  5. ^ Clark, edited by Parveen Kumar, Michael (July 2011). Kumar & Clark's clinical medicine (7th ed.). Edinburgh: Saunders Elsevier. ISBN 978-0-7020-2992-9. 
  6. ^ Locasciulli A, Oneto R, Bacigalupo A, et al. (2007). "Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)". Haematologica 92 (1): 11–8. doi:10.3324/haematol.10075. PMID 17229630. 
  7. ^ a b Tisdale JF, Maciejewski JP, Nunez O, et al. (2002). "Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial". Blood 100 (13): 4668–4670. doi:10.1182/blood-2002-02-0494. PMID 12393567. 
  8. ^ "NIH Clinical Center: Clinical Center News, NIH Clinical Center". Retrieved 2007-12-04. 
  9. ^ Scheinberg, P.; Scheinberg, Philip and Young, Neil S (April 19, 2012). "How I treat acquired aplastic Anemia". Blood 120 (6): 1185–96. doi:10.1182/blood-2011-12-274019. PMC 3418715. PMID 22517900.  Free Text

External links[edit]

Wikipedia content is licensed under the GFDL License
Powered by YouTube
LEGAL
  • Mashpedia © 2014